GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | December 11, 2024 |
PDB ID | UniProt ID ▲ | Title | Descriptor |
---|---|---|---|
7RYN | P06126 | CD1a-sulfatide-gdTCR complex | |
1UJW | P06129 | Structure of the complex between BtuB and Colicin E3 Receptor binding domain | |
3VPH | P06150 | L-lactate dehydrogenase from Thermus caldophilus GK24 complexed with oxamate, NADH and FBP | |
7MD5 | P06213 | Insulin receptor ectodomain dimer complexed with two IRPA-9 partial agonists | |
6VEP | P06213 | Human insulin in complex with the human insulin microreceptor in turn in complex with Fv 83-7 | |
6VEQ | P06213 | Con-Ins G1 in complex with the human insulin microreceptor in turn in complex with Fv 83-7 | |
6CE9 | P06213 | Insulin Receptor ectodomain in complex with two insulin molecules | |
6CEB | P06213 | Insulin Receptor ectodomain in complex with two insulin molecules - C1 symmetry | |
6HN4 | P06213 | Leucine-zippered human insulin receptor ectodomain with single bound insulin - "lower" membrane-proximal part | |
6HN5 | P06213 | Leucine-zippered human insulin receptor ectodomain with single bound insulin - "upper" membrane-distal part | |
7KD6 | P06213 | Insulin Receptor L1-CR plus alphaCT fragment in co-complex with Fv 83-7 and single-chain insulin SCI-b | |
2HR7 | P06213 | Insulin receptor (domains 1-3) | |
3W11 | P06213 | Insulin receptor ectodomain construct comprising domains L1-CR in complex with human insulin, Alpha-CT peptide(704-719) and FAB 83-7 | |
3W12 | P06213 | Insulin receptor ectodomain construct comprising domains L1-CR in complex with high-affinity insulin analogue [D-PRO-B26]-DTI-NH2, alpha-CT peptide(704-719) and FAB 83-7 | |
3W13 | P06213 | Insulin receptor ectodomain construct comprising domains L1-CR in complex with high-affinity insulin analogue [D-PRO-B26]-DTI-NH2, alphact peptide(693-719) and FAB 83-7 | |
4OGA | P06213 | Insulin in complex with Site 1 of the human insulin receptor | |
4XSS | P06213 | Insulin-like growth factor I in complex with site 1 of a hybrid insulin receptor / Type 1 insulin-like growth factor receptor | |
4XST | P06213 | Structure of the endoglycosidase-H treated L1-CR domains of the human insulin receptor in complex with residues 697-719 of the human insulin receptor (A-isoform) | |
4ZXB | P06213 | Structure of the human insulin receptor ectodomain, IRDeltabeta construct, in complex with four Fab molecules | |
5J3H | P06213 | Human insulin receptor domains L1-CR in complex with peptide S519C16 and 83-7 Fv | |
5KQV | P06213 | Insulin receptor ectodomain construct comprising domains L1,CR,L2, FnIII-1 and alphaCT peptide in complex with bovine insulin and FAB 83-14 (REVISED STRUCTURE) | |
7S0Q | P06213 | Head region of a complex of IGF-I with the ectodomain of a hybrid insulin receptor / type 1 insulin-like growth factor receptor | |
7S8V | P06213 | Leg region of a complex of IGF-I with the ectodomain of a hybrid insulin receptor / type 1 insulin-like growth factor receptor | |
7MQO | P06213 | The insulin receptor ectodomain in complex with a venom hybrid insulin analog - "head" region | |
7MQR | P06213 | The insulin receptor ectodomain in complex with four venom hybrid insulins - symmetric conformation | |
7U6E | P06213-2 | Head region of insulin receptor ectodomain (A-isoform) bound to the non-insulin agonist IM462 | |
6EQQ | P06276 | Human butyrylcholinesterase in complex with huprine 19 | |
6QAB | P06276 | Human Butyrylcholinesterase in complex with (S)-N-(1-((2-cycloheptylethyl)amino)-3-(1H-indol-3-yl)-1-oxopropan-2-yl)-N,N-dimethylbutan-1-aminium | |
7AMZ | P06276 | Crystal structure of human Butyrylcholinesterase in complex with N-((2S,3R)-4-((2,2-dimethylpropyl)amino)-3-hydroxy-1-phenylbutan-2-yl)-2,2-diphenylacetamide | |
7AWG | P06276 | Crystal structure of human butyrylcholinesterase in complex with (2-((1-(benzenesulfonyl)-1H-indol-4-yl)oxy)ethyl)(benzyl)amine | |
6I2T | P06276 | CryoEM reconstruction of full-length, fully-glycosylated human butyrylcholinesterase tetramer | |
6QAE | P06276 | Human Butyrylcholinesterase in complex with (S)-N2-butyl-N1-(2-cycloheptylethyl)-3-(1H-indol-3-yl)-N1,N2-dimethylpropane-1,2-diamine | |
6QAC | P06276 | Human Butyrylcholinesterase in complex with (S)-2-(butylamino)-N-(3-cycloheptylpropyl)-3-(1H-indol-3-yl)propanamide | |
6RUA | P06276 | Structure of recombinant human butyrylcholinesterase in complex with a coumarin-based fluorescent probe linked to sulfonamide type inhibitor. | |
6SAM | P06276 | Structure of human butyrylcholinesterase in complex with 1-(2,3-dihydro-1H-inden2-yl)piperidin-3-yl N-phenyl carbamate | |
6EP4 | P06276 | Human butyrylcholinesterase in complex with decamethonium | |
6EQP | P06276 | Human butyrylcholinesterase in complex with ethopropazine | |
6EYF | P06276 | Butyrylcolinesterase expressed in CHO cells co-crystallised with a rivastigmine analogue | |
6R6W | P06276 | Structure of recombinant human butyrylcholinesterase in complex with a fluorescent NBD-based probe | |
6QAD | P06276 | Human Butyrylcholinesterase in complex with ((S)-2-(butylamino)-N-(2-(4-(dimethylamino)cyclohexyl)ethyl)-3-(1H-indol-3-yl)propanamide | |
6T9P | P06276 | Human Butyrylcholinesterase in complex with 2-(N-hydroxyimino)-N-[(1R)-3-{4-[(2-methyl-1H-imidazol-1-yl)methyl]-1H-1,2,3-triazol-1-yl}-1- phenylpropyl]acetamide | |
6T9S | P06276 | Human Butyrylcholinesterase in complex with 2-(N-hydroxyimino)-N-[(1S)-3-{4-[(2-methyl-1H-imidazol-1-yl)methyl]-1H-1,2,3-triazol-1-yl}-1- phenylpropyl]acetamide | |
6XTA | P06276 | Recombinant human butyrylcholinesterase in complex with (2S)-N-[2-(1-benzylazepan-4-yl)ethyl]-2-(butylamino)-3-(1H-indol-3-yl)propanamide | |
7BGC | P06276 | human butyrylcholinesterase in complex with a tacrine-methylanacardate hybrid inhibitor | |
6R6V | P06276 | Structure of recombinant human butyrylcholinesterase in complex with a fluorescent coumarin-based probe | |
6ESJ | P06276 | Human butyrylcholinesterase in complex with propidium | |
6ESY | P06276 | Human butyrylcholinesterase in complex with thioflavine T | |
6EZ2 | P06276 | Human butyrylcholinesterase carbamylated. | |
6I0C | P06276 | Human butyrylcholinesterase in complex with the R enantiomer of a chlorotacrine-tryptophan multi-target inhibitor. | |
6QAA | P06276 | Human Butyrylcholinesterase in complex with (S)-2-(butylamino)-N-(2-cycloheptylethyl)-3-(1H-indol-3-yl)propanamide |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024